204 related articles for article (PubMed ID: 30066873)
1. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.
Wu K; Zhang H; Fu Y; Zhu Y; Kong L; Chen L; Zhao F; Yu L; Chen X
Mol Med Rep; 2018 Sep; 18(3):3411-3420. PubMed ID: 30066873
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Ma FJ; Liu ZB; Hu X; Ling H; Li S; Wu J; Shao ZM
PLoS One; 2014; 9(10):e111639. PubMed ID: 25360699
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
4. Significance of TLR4/MyD88 expression in breast cancer.
Chen X; Zhao F; Zhang H; Zhu Y; Wu K; Tan G
Int J Clin Exp Pathol; 2015; 8(6):7034-9. PubMed ID: 26261595
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
6. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
[TBL] [Abstract][Full Text] [Related]
7. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.
Yang H; Wang B; Wang T; Xu L; He C; Wen H; Yan J; Su H; Zhu X
PLoS One; 2014; 9(10):e109980. PubMed ID: 25299052
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer.
Yue Y; Zhou T; Gao Y; Zhang Z; Li L; Liu L; Shi W; Su L; Cheng B
Tumour Biol; 2017 Mar; 39(3):1010428317694312. PubMed ID: 28347236
[TBL] [Abstract][Full Text] [Related]
11. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
d'Adhemar CJ; Spillane CD; Gallagher MF; Bates M; Costello KM; Barry-O'Crowley J; Haley K; Kernan N; Murphy C; Smyth PC; O'Byrne K; Pennington S; Cooke AA; Ffrench B; Martin CM; O'Donnell D; Hennessy B; Stordal B; Finn S; McCann A; Gleeson N; D'Arcy T; Flood B; O'Neill LA; Sheils O; O'Toole S; O'Leary JJ
PLoS One; 2014; 9(6):e100816. PubMed ID: 24977712
[TBL] [Abstract][Full Text] [Related]
12. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
13. TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6.
Hirano H; Yoshioka T; Yunoue S; Fujio S; Yonezawa H; Niiro T; Habu M; Oyoshi T; Sugata S; Kamezawa T; Arimura H; Hanaya R; Tokimura H; Tokudome M; Arita K
Neuropathology; 2012 Dec; 32(6):628-37. PubMed ID: 22414145
[TBL] [Abstract][Full Text] [Related]
14. [Alveolar macrophage TLR4/MyD88 signaling pathway contributes to ventilator-induced lung injury in rats].
Huang C; Pan L; Lin F; Qian W; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):182-5, 189. PubMed ID: 25652858
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
16. A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro.
Chalmers SA; Eidelman AS; Ewer JC; Ricca JM; Serrano A; Tucker KC; Vail CM; Kurt RA
Cell Immunol; 2013 Apr; 282(2):136-45. PubMed ID: 23770722
[TBL] [Abstract][Full Text] [Related]
17. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia.
Fan Y; Ding Y; Li Y; Zhang D; Yu M; Zhou WF; Kong X
Ital J Pediatr; 2022 May; 48(1):64. PubMed ID: 35505407
[TBL] [Abstract][Full Text] [Related]
19. α7 nicotinic acetylcholine receptor agonist inhibits the damage of rat hippocampal neurons by TLR4/Myd88/NF‑κB signaling pathway during cardiopulmonary bypass.
Chen K; Sun Y; Diao Y; Ji L; Song D; Zhang T
Mol Med Rep; 2017 Oct; 16(4):4770-4776. PubMed ID: 28791395
[TBL] [Abstract][Full Text] [Related]
20. TIFA upregulation after hypoxia-reoxygenation is TLR4- and MyD88-dependent and associated with HMGB1 upregulation and release.
Ding N; Zhang Y; Loughran PA; Wang Q; Tsung A; Billiar TR
Free Radic Biol Med; 2013 Oct; 63():361-7. PubMed ID: 23722163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
